New Collaboration to Understand Zantrene Cardioprotection
Latest announcements
Announcement summary
New Collaboration to Understand Zantrene Cardioprotection
<ul>
<li class="typography-body-regular"><strong>Race Initiates New Collaboration to Understand Zantrene Cardioprotection Mechanism</strong></li>
<li class="typography-body-regular"><br></li>
<li class="typography-body-regular"><strong>Important step in understanding how Zantrene can protect the heart from chemotherapy-induced damage</strong></li>
<li class="typography-body-regular"><br></li>
<li class="typography-body-regular"><strong>Collaboration will use state-of-the-art biochemical, cellular and mouse models of cardioprotection</strong></li>
<li class="typography-body-regular"><br></li>
<li class="typography-body-regular"><strong>Program led by leading international cardio-oncologist Dr Brian Jensen of the McAllister Heart Institute, University of North Carolina at Chapel Hill, USA</strong></li>
</ul>
Ask a question
Your question will be sent privately to Racura Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Racura Oncology a question about this announcement.